Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
SpaceX IPO buzz is electric. Here are the two simplest routes retail investors can use to access shares at the IPO pr...
As the AI era expands, investors are eyeing a broader landscape beyond Nvidia. This article explores a rising AI infr...
February can be a smart time for energy-focused income strategies. This guide highlights two durable dividend stocks ...
CoreWeave stock gets headlines can spark investor interest, but smart portfolios look beyond headlines. This guide ex...
Gladstone Investment faces a quarterly miss that pressures its 5.7% yield, spotlighting the risks and resilience of a...
The Strait of Hormuz is finally reopening after months of disruption, but energy flows are far from back to normal. A...
Investors are buzzing about SpaceX's ambitious revenue target for 2030 and a bold rival coming from AI. This guide br...
Pipelines may not grab headlines, but their steady cash flow powers dividends for investors who plan ahead. Learn how...
A sudden market move rattled investors in the card and payments space. This analysis breaks down why american express...
Microsoft stock sinking today has investors looking past a single bad headline. This deep-dive explains the drivers b...
Casella Waste Systems has seen a notable share-price pullback. A new stake by 4D Advisors adds a layer of intrigue. T...